Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-19

Clinical Trial Update: Pectoralis (II) Block With Liposomal Bupivacaine vs Bupivacaine for Breast Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial comparing pectoralis (II) block with liposomal bupivacaine versus bupivacaine for breast surgery; study terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Prisma Health-Upstate | Conditions: Pain, Postoperative | Phase 4 | Status: TERMINATED | Results posted: 2020-11-19